| Product Name | MF | CAS | Details |
|---|
| BRD4 Inhibitor-30 | 1789731-20-9 | Details |
| BTK-IN-30 | C23H21F2N5O3 | 2662512-15-2 | Details |
| CB7993113 | C15H10BrNO5 | 819827-50-4 | Details |
| CDK2-IN-18 | 364735-73-9 | Details |
| Anticancer agent 183 | 3018960-58-9 | Details |
| cGAS-IN-2 | C16H18Cl2N2O2 | 2765273-11-6 | Details |
| Antibacterial agent 169 | 2879255-03-3 | Details |
| COX-2-IN-43 | C18H11Cl2F3N2O3 | 1023524-40-4 | Details |
| Akt1-IN-3 | C37H33N7O3 | 3033576-50-7 | Details |
| CSF1R-IN-21 | C24H20F3N5O3 | 2935479-62-0 | Details |
| Ack1 inhibitor 2 | 1196392-26-3 | Details |
| Antitumor agent-144 | C25H26N4O4 | 137346-42-0 | Details |
| AR/AR-V7-IN-1 | 2964558-54-9 | Details |
| ANO61 | C18H20N2O2 | 940476-20-0 | Details |
| Anticancer agent 129 | C18H17N3 | 135882-37-0 | Details |
| Arginase inhibitor 7 | 2377392-07-7 | Details |
| COX-1-IN-1 | C20H21NO3 | 1369503-03-6 | Details |
| ATAD2-IN-1 | C22H26N6O5 | 3004556-06-0 | Details |
| Antidiabetic agent 5 | 2152667-21-3 | Details |
| ChEs/MAOs-IN-2 | 693268-77-8 | Details |
| c-Myc inhibitor 14 | C38H52BN3O7 | 2581994-88-7 | Details |
| C3TD879 | C22H28N4O | 2850259-33-3 | Details |
| CD 10899 | 1331770-20-7 | Details |
| BChE-IN-25 | C17H23NO2 | 79183-25-8 | Details |
| CCR8 antagonist 3 | C29H33N3O4 | 912463-57-1 | Details |
| CHI3L1-IN-2 | 2982257-63-4 | Details |
| CDK2-IN-23 | C20H27F3N6O3S | 2488073-20-5 | Details |
| Arfolitixorin sulfate | C20H25N7O10S | 149930-93-8 | Details |
| AEP-IN-3 | 2978521-26-3 | Details |
| CDK8-IN-14 | C18H13N3O2 | 2924193-12-2 | Details |
| AS115 | C21H32FNO4 | 926657-43-4 | Details |
| Aurora kinase inhibitor-11 | C11H10BrN3OS | 923946-98-9 | Details |
| Casein kinase 1δ-IN-15 | 2765264-27-3 | Details |
| BAY-155 | C28H28F3N7OS | 2163769-52-4 | Details |
| AQIM-I | 2247881-73-6 | Details |
| Calcium mesoxalate | C6H6CaO12 | 21085-60-9 | Details |
| CRT0066101 | C18H22N6O | 956123-34-5 | Details |
| ATF4-IN-1 | 2991057-76-0 | Details |
| Antifungal agent 87 | 692730-21-5 | Details |
| CBR1-IN-5 | C17H13ClN2O3 | 1798284-62-4 | Details |
| ALR-38 | C19H17NO4 | 241127-61-7 | Details |
| AKR1C3-IN-12 | C17H14N2O3 | 891075-67-5 | Details |
| AR antagonist 5 | 2902679-53-0 | Details |
| BIO-7488 | C23H25N7O3 | 2573211-25-1 | Details |
| Atrazine-3-mercaptopropanoic acid | C11H19N5O2S | 125454-31-1 | Details |
| Anti-infective agent 9 | C14H11F3N4S2 | 758689-17-7 | Details |
| CEP-28122 mesylate hydrochloride | C29H40Cl2N6O6S | 1354545-57-5 | Details |
| BTL-MK | C24H24O6 | 2758569-43-4 | Details |
| Antifungal agent 100 | C23H21N3O4S | 2975157-18-5 | Details |
| CBR1-IN-7 | 1119826-35-5 | Details |
| CHI3L1-IN-1 | 2982256-78-8 | Details |
| TM38837 | 1034264-77-1 | Details |
| BET-IN-23 | C29H34FN3O5 | 2953287-57-3 | Details |
| Antitumor agent-122 | 2378641-43-9 | Details |
| BAY-5516 | 2891706-79-7 | Details |
| CARM1-IN-4 | 2878481-07-1 | Details |
| BRD4 Inhibitor-29 | C21H28N2O3 | 902563-50-2 | Details |
| BaENR-IN-1 | C12H8ClNO4 | 1071966-17-0 | Details |
| AKT-IN-14 free base | C22H21BrF2N4OS | 2781918-27-0 | Details |
| Akt1-IN-4 | C37H31N7O3 | 3033577-05-5 | Details |
| BAY-6096 | C21H23N6O2.Cl | 2313483-41-7 | Details |
| ATF4-IN-2 | 2991057-60-2 | Details |
| ALDH1A1-IN-4 | C20H15ClN2 | 23982-86-7 | Details |
| COX-2-IN-40 | C19H11ClO3 | 444790-64-1 | Details |
| AQP3-IN-1 | C11H9AuCl2N2 | 198711-19-2 | Details |
| Ack1 inhibitor 1 | 2924415-92-7 | Details |
| DHODH-IN-24 | 418775-30-1 | Details |
| CYP19A1/CYP11B2-IN-1 | C12H11N3O | 183500-36-9 | Details |
| DB18 | C24H18ClN7O3 | 2587177-94-2 | Details |
| DCLK1-IN-5 | 3028774-14-0 | Details |
| CVN293 | 2815296-08-1 | Details |
| DHODH-IN-25 | C22H19ClF5N3O5 | 2619531-95-0 | Details |
| DDABT1 | C40H34N4O4 | 2777045-35-7 | Details |
| CTPS1-IN-2 | C24H27N7O5S | 2377000-84-3 | Details |
| CVM-05-002 | C16H14N4O3S2 | 2428738-43-4 | Details |
| COX-2-IN-39 | C17H17N3O3S2 | 1018480-89-1 | Details |
| AKT-IN-14 | C22H21BrF2N4OS.ClH | 2781918-35-0 | Details |
| Anti-osteoporosis agent-3 | 2944463-16-3 | Details |
| Antitumor agent-138 | C20H21N3O4 | 2975168-22-8 | Details |
| AMG-193 | C22H19F3N4O3 | 2790567-82-5 | Details |
| Antiproliferative agent-22 | C17H13N3O3 | 1374305-45-9 | Details |
| CSF1R-IN-23 | C27H37N3O2 | 2935480-17-2 | Details |
| CZL80 | C19H14N2O4S | 313482-91-6 | Details |
| CYP4A11/CYP4F2-IN-2 | 2280834-99-1 | Details |
| CVN766 | C20H21F3N8O | 1803557-42-7 | Details |
| CXF-009 | C33H38N8O5 | 2727084-00-4 | Details |
| Antibacterial agent 172 | C21H21N9O5S2 | 3023114-93-1 | Details |
| Antitumor agent-100 | C17H14ClN3O | 2841750-32-9 | Details |
| CDK2-IN-27 | C18H21N7O2 | 2927473-94-5 | Details |
| BET-IN-20 | 1300735-76-5 | Details |
| ASN02563583 | C25H24N4O3S | 483283-39-2 | Details |
| COX-1/2-IN-6 | 327024-84-0 | Details |
| CBR1-IN-3 | C16H11ClN2O3 | 891101-69-2 | Details |
| CTSL/CAPN1-IN-2 | C34H40N4O6 | 2410075-64-6 | Details |
| CXF-007 | C34H33N7O5 | 2727083-99-8 | Details |
| CSF1R-IN-20 | 2935479-57-3 | Details |
| Antiangiogenic agent 5 | C25H22F3N5O3 | 2095397-52-5 | Details |
| CSF1R-IN-22 | C20H20N6O3 | 2760585-35-9 | Details |
| BChE-IN-23 | C20H19FN2O | 2020357-32-6 | Details |
| CBR1-IN-4 | 1798284-64-6 | Details |
| Product Total： Product Page： | ||||
| 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||